Your browser doesn't support javascript.
loading
Navigating complexity with low-crossing profile dual-layer micromesh carotid stent: implications for contemporary carotid artery stenting outcomes (ROADSAVER study insights).
Langhoff, Ralf; Schwindt, Arne; Vajda, Zsolt; Gjoreski, Aleksander; Faurie, Benjamin; Kedev, Sasko; Müller-Hülsbeck, Stefan.
Afiliación
  • Langhoff R; Department of Angiology, Brandenburg Medical School Theodor Fontane, Campus Clinic Brandenburg, Brandenburg an der Havel and Sankt Gertrauden Hospital, Berlin, Germany - ralf.langhoff@sankt-gertrauden.de.
  • Schwindt A; Department of Vascular Surgery, St. Franziskus-Hospital, Münster, Germany.
  • Vajda Z; Neurovascular Unit, Moritz Kaposi Teaching Hospital, Kaposvár, Hungary.
  • Gjoreski A; Department of Radiology, Fejér County Szent György University Teaching Hospital, Székesfehérvár, Hungary.
  • Faurie B; Department for Diagnostic and Interventional Radiology, Clinical Hospital "Acibadem Sistina", Skopje, Republic of North Macedonia.
  • Kedev S; Infirmerie Protestante, Lyon, France.
  • Müller-Hülsbeck S; Department of Cardiology, Faculty of Medicine, University Clinic of Cardiology, University of St. Cyril and Methodius, Skopje, Republic of North Macedonia.
J Cardiovasc Surg (Torino) ; 65(3): 205-212, 2024 Jun.
Article en En | MEDLINE | ID: mdl-39007554
ABSTRACT

BACKGROUND:

The safety and efficacy of carotid artery stenting (CAS) can be affected by certain technical and anatomical factors. However, it is not known whether the use of a dual-layer micromesh stent (DLMS) with a low-crossing profile could reduce the risks associated with complex vascular anatomies during CAS.

METHODS:

This study involved 1965 asymptomatic or symptomatic carotid artery stenosis patients who received the Roadsaver DLMS during CAS, as part of a prospective, multicenter observational ROADSAVER study, conducted from January 2018 to February 2021. The primary outcome was the 30-day rate of major adverse events (MAE; i.e. any death or stroke) after CAS. Procedural details and outcomes were compared between patients with complex anatomical features and those without.

RESULTS:

One or more complex anatomical characteristics were identified in 1639 (83.4%) patents. Patients with complex anatomies were older and had a higher prevalence of arterial hypertension, cardiovascular disease, and prior stroke. Between patients with or without complex anatomical features, no significant differences were found either in procedural techniques, or in 30-day MAE (age-adjusted odds ratio (95% CI) for complexities vs. no complexities 0.76 (0.35, 1.66); p=0.4905) and any stroke (age-adjusted odds ratio (95% CI) for complexities vs. no complexities 0.89 (0.37, 2.17); p=0.8032) incidence. Furthermore, neither the presence of specific types of anatomic complexity nor their number (per patient) markedly influenced the 30-day MAE and any stroke incidence.

CONCLUSIONS:

In this real-world cohort of patients undergoing CAS with the Roadsaver DLMS, no significant difference in the occurrence of 30-day MAE and any stroke was observed between patients with or without high-risk anatomical features.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diseño de Prótesis / Stents / Estenosis Carotídea / Accidente Cerebrovascular / Procedimientos Endovasculares Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Cardiovasc Surg (Torino) Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diseño de Prótesis / Stents / Estenosis Carotídea / Accidente Cerebrovascular / Procedimientos Endovasculares Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Cardiovasc Surg (Torino) Año: 2024 Tipo del documento: Article